Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABUS Arbutus Biopharma Corporation

盘前交易 07-26 05:31:02 EDT

3.92

+0.05

+1.29%

最高3.98	最低3.86	成交量91.27万
今开3.90	昨收3.87	日振幅3.23%
总市值7.40亿	流通市值5.31亿	总股本1.89亿
成交额358.82万	换手率0.67%	流通股本1.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABUS","market":"US","secType":"STK","nameCN":"Arbutus Biopharma Corporation","latestPrice":3.92,"timestamp":1721937600000,"preClose":3.87,"halted":0,"volume":912687,"delay":0,"floatShares":135490984,"shares":188717409,"eps":-0.439987,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.05,"latestTime":"07-26 05:31:02 EDT","open":3.9,"high":3.98,"low":3.855,"amount":3588159.3024819,"amplitude":0.0323,"askPrice":4.32,"askSize":100,"bidPrice":3.95,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-0.439987,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722000600000},"adr":0,"listingDate":1184904000000,"adjPreClose":3.92,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.92,"latestTime":"19:44 EDT","volume":38714,"amount":151757.85,"timestamp":1721951058008},"volumeRatio":1.2323842296945593,"impliedVol":1.0811,"impliedVolPercentile":0.7012},"requestUrl":"/m/hq/s/ABUS/wiki","defaultTab":"wiki","newsList":[{"id":"2452664211","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452664211","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452664211?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:11","pubTimestamp":1721229067,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时11分，Arbutus Biopharma Corporation股票出现波动，股价快速下跌5.03%。截至发稿，该股报3.69美元/股，成交量30.0829万股，换手率0.16%，振幅3.61%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为2.56%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Moolec Science Sa C/Wts 涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2893.86%、1299.57%、271.34%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172311079681db31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172311079681db31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2451672872","title":"Arbutus Biopharma Corporation盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451672872","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451672872?lang=zh_cn&edition=full","pubTime":"2024-07-16 03:08","pubTimestamp":1721070497,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日03时08分，Arbutus Biopharma Corporation股票出现波动，股价大幅上涨5.01%。截至发稿，该股报3.77美元/股，成交量88.1699万股，换手率0.47%，振幅5.57%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Revolution Medicines Inc C/Wts 17/12/2026 、Aeon Biopharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3418.84%、180.07%、139.65%，振幅较大的相关个股有Aeon Biopharma, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Scinai Immunotherapeutics Ltd，振幅分别为150.36%、110.42%、91.37%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716030817aef9c766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716030817aef9c766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2449064377","title":"Arbutus Biopharma Corporation盘中异动 大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449064377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449064377?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:03","pubTimestamp":1720447434,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时03分，Arbutus Biopharma Corporation股票出现波动，股价快速上涨5.45%。截至发稿，该股报3.29美元/股，成交量14.9571万股，换手率0.08%，振幅4.33%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Virpax Pharmaceuticals, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为830.14%、162.26%、133.91%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、34.48%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082203559681aaa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082203559681aaa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441509727","title":"Arbutus Biopharma Corporation盘中异动 大幅下挫5.09%报3.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441509727","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441509727?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:52","pubTimestamp":1717786377,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时52分，Arbutus Biopharma Corporation股票出现异动，股价大幅跳水5.09%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.01%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。消息层面，截至02时52分，《JMP Securities维持Arbutus Biopharma买入评级，维持目标价4美元》资讯为影响Arbutus Biopharma Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608025258941ed5b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608025258941ed5b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441771272","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.09%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441771272","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441771272?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:30","pubTimestamp":1717597830,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时30分，Arbutus Biopharma Corporation股票出现异动，股价急速上涨5.09%。截至发稿，该股报3.51美元/股，成交量32.6734万股，换手率0.17%，振幅4.19%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Kineta, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、诺瓦瓦克斯医药涨幅较大，Adial Pharmaceuticals, Inc、Cns Pharmaceuticals, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为47.42%、43.91%、10.03%，振幅较大的相关个股有Biocardia Inc C/Wts 06/08/2024、Kineta, Inc.、Silo Pharma, Inc.，振幅分别为41.80%、36.42%、23.56%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522303196812336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522303196812336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2437567763","title":"Arbutus Biopharma Corporation盘中异动 早盘大幅下挫5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437567763","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437567763?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:47","pubTimestamp":1716472060,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日21时47分，Arbutus Biopharma Corporation股票出现异动，股价快速下挫5.28%。截至发稿，该股报3.23美元/股，成交量17.5796万股，换手率0.09%，振幅5.57%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Geovax Labs Inc C/Wts 29/09/2025、Altamira Therapeutics Ltd.涨幅较大，Altamira Therapeutics Ltd.、Theriva Biologics, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为838.98%、91.60%、37.83%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Theriva Biologics, Inc.、Akari Therapeutics Plc，振幅分别为29.36%、26.35%、22.51%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523214740aef15756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523214740aef15756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2437947942","title":"Arbutus Biopharma Corporation盘中异动 早盘大幅上涨5.14%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437947942","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437947942?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:34","pubTimestamp":1716388455,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时34分，Arbutus Biopharma Corporation股票出现波动，股价快速拉升5.14%。截至发稿，该股报3.38美元/股，成交量51.2246万股，换手率0.27%，振幅5.45%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Igm Biosciences, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Curevac N.V.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为278.65%、136.91%、37.90%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts 、Oragenics Inc.，振幅分别为57.14%、48.75%、47.70%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522223416941e9752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522223416941e9752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2436290917","title":"BUZZ-投资者怀特福特敦促公司停止出售股份并寻找合作伙伴，Arbutus 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2436290917","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436290917?lang=zh_cn&edition=full","pubTime":"2024-05-17 22:43","pubTimestamp":1715956987,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月17日 - ** Arbutus生物制药公司  股价上涨1%至2.92美元** Whitefort Capital Management敦促ABUS停止发行股票 (link)，并为其乙型肝炎病毒治疗组合寻找潜在合作伙伴。** 根据路透看到的一封信，该投资公司批评安博利用股票销售为其肝炎研究提供资金。 ** 该投资公司认为，在Arbutus股东等待 (link)，莫德纳  和辉瑞  与COVID-19疫苗有关的专利侵权索赔案的结论时，继续出售股票将损害Arbutus股东的利益。** 截至上次收盘，股价累计上涨15.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","ABUS"],"gpt_icon":0},{"id":"2436913598","title":"投资者 Whitefort 敦促 Arbutus 生物制药公司停止出售股票，寻找合作伙伴","url":"https://stock-news.laohu8.com/highlight/detail?id=2436913598","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436913598?lang=zh_cn&edition=full","pubTime":"2024-05-17 20:00","pubTimestamp":1715947205,"startTime":"0","endTime":"0","summary":" Svea Herbst-Bayliss    路透纽约5月17日 - 据路透报道，Whitefort资本管理公司在一封信中敦促Arbutus生物制药公司  停止发行股票，并在今年启动战略审查，为其乙型肝炎病毒治疗组合寻找潜在的合作伙伴。Arbutus 的代表没有立即回应置评请求。该投资公司认为，在Arbutus股东等待对莫德纳  和辉瑞  提出的与COVID-19疫苗有关的专利侵权索赔的结论时，继续出售股票会损害他们的利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4532","BK4139","BK4588","BK4551","BK4501","MRNA","BK4533","BK4585","PFE","BK4568","ABUS"],"gpt_icon":0},{"id":"2434692808","title":"Arbutus Biopharma Corporation2024财年第一财季实现净利润-17.88百万美元，同比减少9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434692808","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434692808?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:21","pubTimestamp":1715358065,"startTime":"0","endTime":"0","summary":"3月31日，Arbutus Biopharma Corporation公布财报，公告显示公司2024财年第一财季净利润为-17.88百万美元，同比减少9.42%；其中营业收入为1.53百万美元，同比减少77.13%，每股基本收益为-0.10美元。从资产负债表来看，Arbutus Biopharma Corporation总负债35.65百万美元，其中短期债务502000.00美元，资产负债比为0.05，流动比率为0.07。机构评级：截至2024年3月31日，当前有5家机构对Arbutus Biopharma Corporation目标价做出预测，其中目标均价为4.40美元，其中最低目标价为4.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511002116875170c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511002116875170c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS"],"gpt_icon":0},{"id":"2434686938","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434686938","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434686938?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:01","pubTimestamp":1715353262,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时01分，Arbutus Biopharma Corporation股票出现波动，股价大幅下挫5.09%。截至发稿，该股报2.79美元/股，成交量12.7932万股，换手率0.07%，振幅5.77%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.19%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102301037a59432e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102301037a59432e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2432700399","title":"Arbutus Biopharma Corporation盘中异动 早盘快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432700399","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432700399?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:44","pubTimestamp":1714743860,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时44分，Arbutus Biopharma Corporation股票出现波动，股价大幅拉升5.22%。截至发稿，该股报2.82美元/股，成交量11.4501万股，换手率0.06%，振幅4.10%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Vaxxinity, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为92.40%、26.16%、15.22%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为54.50%、30.65%、26.55%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503214420861ead78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503214420861ead78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2425407566","title":"Arbutus Biopharma Corporation盘中异动 股价大涨5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425407566","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425407566?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:00","pubTimestamp":1712325635,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时00分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨5.00%。截至发稿，该股报3.15美元/股，成交量53.6752万股，换手率0.30%，振幅5.33%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为56.48%、51.81%、25.05%，振幅较大的相关个股有Candel Therapeutics, Inc.、Mink Therapeutics, Inc.、Protara Therapeutics, Inc.，振幅分别为30.63%、29.10%、24.13%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220036861e38ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220036861e38ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2424339217","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424339217","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424339217?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:31","pubTimestamp":1712237487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时31分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨5.10%。截至发稿，该股报3.07美元/股，成交量25.3258万股，换手率0.14%，振幅4.45%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Tc Biopharm  Plc、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Tc Biopharm  Plc、Effector Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为511.15%、29.36%、16.09%，振幅较大的相关个股有Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Tevogen Bio Holdings Inc.，振幅分别为23.85%、12.46%、10.88%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213128861e364b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213128861e364b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2424582969","title":"Arbutus Biopharma Corporation盘中异动 股价大涨13.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424582969","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424582969?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:15","pubTimestamp":1712160942,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时15分，Arbutus Biopharma Corporation股票出现波动，股价快速拉升13.10%。截至发稿，该股报2.85美元/股，成交量40.9502万股，换手率0.23%，振幅19.44%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为509.90%、467.59%、71.66%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进，振幅分别为97.51%、58.48%、44.44%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040015437a50fc2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040015437a50fc2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2417799040","title":"Arbutus Biopharma Corporation2023财年实现净利润-72.85百万美元，同比减少4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417799040","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417799040?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:24","pubTimestamp":1709828664,"startTime":"0","endTime":"0","summary":"12月31日，Arbutus Biopharma Corporation公布财报，公告显示公司2023财年净利润为-72.85百万美元，同比减少4.88%；其中营业收入为18.14百万美元，同比减少53.51%，每股基本收益为-0.44美元。从资产负债表来看，Arbutus Biopharma Corporation总负债38.38百万美元，其中短期债务425000.00美元，资产负债比为0.04，流动比率为0.06。机构评级：截至2023年12月31日，当前有5家机构对Arbutus Biopharma Corporation目标价做出预测，其中目标均价为4.40美元，其中最低目标价为4.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024368b1424a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024368b1424a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS"],"gpt_icon":0},{"id":"2415526900","title":"Arbutus Biopharma 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2415526900","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415526900?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:39","pubTimestamp":1709221164,"startTime":"0","endTime":"0","summary":"   * Arbutus Biopharma Corp   报告了截至12月底的季度调整后每股亏损12美分，高于去年同期的每股-14美分。华尔街预期为每股-13美分至-10美分。* 营收同比下降 65.7%，降至 215 万美元；分析师预期为 479 万美元。* Arbutus Biopharma Corp公布的本季度每股收益为亏损12美分。* 本季度，Arbutus Biopharma Corp 的股价上涨了 15.2%。* 在过去 30 天内，没有覆盖该公司的分析师对盈利预期进行修正。* 医药同行的平均一致建议也是 \"买入\"。华尔街对 Arbutus Biopharma Corp 的 12 个月目标价中位数为 4.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2416852727","title":"Arbutus Biopharma Corporation盘中异动 早盘急速下挫5.03%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416852727","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416852727?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:38","pubTimestamp":1709221093,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时38分，Arbutus Biopharma Corporation股票出现波动，股价急速下挫5.03%。截至发稿，该股报2.74美元/股，成交量29.4465万股，换手率0.18%，振幅4.51%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为1.69%。其相关个股中，Enveric Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Adial Pharmaceuticals, Inc涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃，换手率分别为3276.21%、1258.57%、59.29%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Biocardia Inc C/Wts 06/08/2024，振幅分别为164.60%、95.99%、75.00%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292338137915fb8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292338137915fb8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2414876716","title":"Arbutus Biopharma Corp    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414876716","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414876716?lang=zh_cn&edition=full","pubTime":"2024-02-27 20:33","pubTimestamp":1709037215,"startTime":"0","endTime":"0","summary":"   * Arbutus Biopharma Corp    将于2月29日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于宾夕法尼亚州沃明斯特的公司的营收将从去年同期的625万美元降至479.3万美元，降幅为23.2%。* LSEG 分析师对 Arbutus Biopharma Corp 的平均预期是每股亏损 12 美分。* 华尔街对 Arbutus Biopharma Corp 的 12 个月目标价中值为 4.00 美元，高于其上一次收盘价 2.92 美元。2月27日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS"],"gpt_icon":0},{"id":"2410101052","title":"Arbutus Biopharma Corp盘中异动 大幅上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410101052","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410101052?lang=zh_cn&edition=full","pubTime":"2024-02-09 23:31","pubTimestamp":1707492667,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日23时31分，Arbutus Biopharma Corp股票出现波动，股价快速拉升5.31%。截至发稿，该股报2.68美元/股，成交量96.6264万股，换手率0.58%，振幅3.94%。Arbutus Biopharma Corp股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Xenetic Biosciences Inc C/Wts 19/07/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Gri Bio Inc、Tenax Therapeutics Inc较为活跃，换手率分别为2434.50%、75.96%、67.73%，振幅较大的相关个股有Tc Biopharm  Plc、Gri Bio Inc、Okyo Pharma Ltd Com Npv ，振幅分别为37.26%、28.80%、21.68%。Arbutus Biopharma Corp公司简介：Arbutus Biopharma Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402092331077a42d63b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402092331077a42d63b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arbutusbio.com","stockEarnings":[{"period":"1week","weight":0.0623},{"period":"1month","weight":0.2852},{"period":"3month","weight":0.4359},{"period":"6month","weight":0.6471},{"period":"1year","weight":0.8233},{"period":"ytd","weight":0.568}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司，利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法，这些疗法可以潜在地结合起来，为慢性乙型肝炎病毒（HBV）感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran（AB-729）和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据，证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":2,"riseRate":0.777778,"avgChangeRate":0.069865},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.063185},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.000549},{"month":5,"riseRate":0.444444,"avgChangeRate":0.054581},{"month":6,"riseRate":0.555556,"avgChangeRate":0.017563},{"month":7,"riseRate":0.444444,"avgChangeRate":0.172846},{"month":8,"riseRate":0.25,"avgChangeRate":-0.040774},{"month":9,"riseRate":0.555556,"avgChangeRate":0.063767},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.102567},{"month":11,"riseRate":0.666667,"avgChangeRate":0.06501},{"month":12,"riseRate":0.333333,"avgChangeRate":0.041025}],"exchange":"NASDAQ","name":"Arbutus Biopharma Corporation","nameEN":"Arbutus Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arbutus Biopharma Corporation,ABUS,Arbutus Biopharma Corporation股票,Arbutus Biopharma Corporation股票老虎,Arbutus Biopharma Corporation股票老虎国际,Arbutus Biopharma Corporation行情,Arbutus Biopharma Corporation股票行情,Arbutus Biopharma Corporation股价,Arbutus Biopharma Corporation股市,Arbutus Biopharma Corporation股票价格,Arbutus Biopharma Corporation股票交易,Arbutus Biopharma Corporation股票购买,Arbutus Biopharma Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况